These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 37585253)
1. Nitrous Oxide Reduced Suicidal Ideation in Treatment-Resistant Major Depression in Exploratory Analysis. de Leon VC; Kumar A; Nagele P; Palanca BJ; Gott B; Janski A; Zorumski CF; Conway CR J Clin Psychiatry; 2023 Aug; 84(5):. PubMed ID: 37585253 [No Abstract] [Full Text] [Related]
2. Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial. Ionescu DF; Bentley KH; Eikermann M; Taylor N; Akeju O; Swee MB; Pavone KJ; Petrie SR; Dording C; Mischoulon D; Alpert JE; Brown EN; Baer L; Nock MK; Fava M; Cusin C J Affect Disord; 2019 Jan; 243():516-524. PubMed ID: 30286416 [TBL] [Abstract][Full Text] [Related]
3. Rapid and sustained antidepressant effects of intravenous ketamine in treatment-resistant major depressive disorder and suicidal ideation: a randomized clinical trial. Zolghadriha A; Anjomshoaa A; Jamshidi MR; Taherkhani F BMC Psychiatry; 2024 May; 24(1):341. PubMed ID: 38714931 [TBL] [Abstract][Full Text] [Related]
4. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder. DiazGranados N; Ibrahim LA; Brutsche NE; Ameli R; Henter ID; Luckenbaugh DA; Machado-Vieira R; Zarate CA J Clin Psychiatry; 2010 Dec; 71(12):1605-11. PubMed ID: 20673547 [TBL] [Abstract][Full Text] [Related]
5. Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study. Ionescu DF; Swee MB; Pavone KJ; Taylor N; Akeju O; Baer L; Nyer M; Cassano P; Mischoulon D; Alpert JE; Brown EN; Nock MK; Fava M; Cusin C J Clin Psychiatry; 2016 Jun; 77(6):e719-25. PubMed ID: 27232360 [TBL] [Abstract][Full Text] [Related]
6. A Randomized, Double-Blind, Midazolam-Controlled Trial of Low-Dose Ketamine Infusion in Patients With Treatment-Resistant Depression and Prominent Suicidal Ideation. Su TP; Li CT; Lin WC; Wu HJ; Tsai SJ; Bai YM; Mao WC; Tu PC; Chen LF; Li WC; Chen MH Int J Neuropsychopharmacol; 2023 May; 26(5):331-339. PubMed ID: 36966411 [TBL] [Abstract][Full Text] [Related]
7. Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials. Ballard ED; Wills K; Lally N; Richards EM; Luckenbaugh DA; Walls T; Ameli R; Niciu MJ; Brutsche NE; Park L; Zarate CA J Affect Disord; 2017 Aug; 218():195-200. PubMed ID: 28477497 [TBL] [Abstract][Full Text] [Related]
8. Association of anhedonia and suicidal ideation in patients with treatment-refractory depression after intravenous ketamine infusions. Zheng W; Gu LM; Yang XH; Zhou YL; Wang CY; Lan XF; Zhang B; Ning YP Int J Psychiatry Clin Pract; 2023 Jun; 27(2):145-150. PubMed ID: 36309806 [TBL] [Abstract][Full Text] [Related]
10. Nitrous Oxide for Treatment-Resistant Major Depression: A Proof-of-Concept Trial. Nagele P; Duma A; Kopec M; Gebara MA; Parsoei A; Walker M; Janski A; Panagopoulos VN; Cristancho P; Miller JP; Zorumski CF; Conway CR Biol Psychiatry; 2015 Jul; 78(1):10-18. PubMed ID: 25577164 [TBL] [Abstract][Full Text] [Related]
11. Neural correlates of suicidal ideation and its reduction in depression. Ballard ED; Lally N; Nugent AC; Furey ML; Luckenbaugh DA; Zarate CA Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25550331 [TBL] [Abstract][Full Text] [Related]
12. Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial. Grunebaum MF; Galfalvy HC; Choo TH; Keilp JG; Moitra VK; Parris MS; Marver JE; Burke AK; Milak MS; Sublette ME; Oquendo MA; Mann JJ Am J Psychiatry; 2018 Apr; 175(4):327-335. PubMed ID: 29202655 [TBL] [Abstract][Full Text] [Related]
13. Nitrous Oxide: an emerging novel treatment for treatment-resistant depression. Quach DF; de Leon VC; Conway CR J Neurol Sci; 2022 Mar; 434():120092. PubMed ID: 34953347 [TBL] [Abstract][Full Text] [Related]
14. A preliminary study of anti-suicidal efficacy of repeated ketamine infusions in depression with suicidal ideation. Zhan Y; Zhang B; Zhou Y; Zheng W; Liu W; Wang C; Li H; Chen L; Yu L; Walter M; Li M; Li MD; Ning Y J Affect Disord; 2019 May; 251():205-212. PubMed ID: 30927581 [TBL] [Abstract][Full Text] [Related]
15. Role of Ketamine in Severe Depression with suicidal ideation - Insights from a Case Study. Gurnani T; Khurshid KA Asian J Psychiatr; 2017 Oct; 29():112-113. PubMed ID: 29061405 [No Abstract] [Full Text] [Related]
16. Treatment-resistant depression patients with baseline suicidal ideation required more treatments to achieve therapeutic response with ketamine/esketamine. Singh B; Vande Voort JL; Pazdernik VK; Frye MA; Kung S J Affect Disord; 2024 Apr; 351():534-540. PubMed ID: 38302067 [TBL] [Abstract][Full Text] [Related]
17. Subanesthetic ketamine infusions for suicide ideation in patients with bipolar and unipolar treatment refractory depression. Kang MJY; Kulcar E; Chandrasena R; Anjum MR; Fairbairn J; Hawken ER; Vazquez GH Psychiatry Res; 2021 Feb; 296():113645. PubMed ID: 33360430 [TBL] [Abstract][Full Text] [Related]
18. Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant. Ballard ED; Luckenbaugh DA; Richards EM; Walls TL; Brutsché NE; Ameli R; Niciu MJ; Vande Voort JL; Zarate CA J Psychiatr Res; 2015 Sep; 68():68-73. PubMed ID: 26228403 [TBL] [Abstract][Full Text] [Related]